These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1509909)
1. [Metastatic renal carcinoma: regression of pulmonary metastasis and anemia after interleukin-2r immunotherapy]. García Riestra V; López Díez E; Constenla Figueiras M; Fernández García L Actas Urol Esp; 1992 May; 16(5):436-9. PubMed ID: 1509909 [TBL] [Abstract][Full Text] [Related]
2. Successful treatment of renal cell carcinoma with mediastinal lymph node metastasis by interleukin-2: a case report. Tokunaga M; Masuda A; Mukai M; Nakamura H; Iwaki K; Terachi T Tokai J Exp Clin Med; 2005 Jul; 30(2):111-5. PubMed ID: 16146201 [TBL] [Abstract][Full Text] [Related]
3. "Late" regressions of metastases from renal cancer after a period of disease progression continuing the same intermittent low dose immunotherapy regimen. Giacosa R; Santi R; Vaglio A; Pavone L; Ferrozzi F; Passalacqua R; Buzio C Acta Biomed; 2004 Aug; 75(2):126-30. PubMed ID: 15481703 [TBL] [Abstract][Full Text] [Related]
4. [Renal cell carcinoma metastatic to the base of tongue: a case report]. Kyan A; Kato SN Hinyokika Kiyo; 2004 Nov; 50(11):791-3. PubMed ID: 15628540 [TBL] [Abstract][Full Text] [Related]
5. [A case of complete regression of metastatic renal cell carcinoma following corticosteroid treatment]. Tanaka M; Fukuda H; Higashi Y Hinyokika Kiyo; 2003 Apr; 49(4):225-8. PubMed ID: 12784718 [TBL] [Abstract][Full Text] [Related]
6. Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma. Belldegrun A; Shvarts O; Figlin RA Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S88-92. PubMed ID: 10685666 [TBL] [Abstract][Full Text] [Related]
7. [Bilateral adrenal masses from renal cell carcinoma: a case report]. Shioi K; Muraoka K; Tomoda T; Yoshida M; Takase K; Kishi H; Noguchi S Hinyokika Kiyo; 2006 Jan; 52(1):19-21. PubMed ID: 16479984 [TBL] [Abstract][Full Text] [Related]
8. [A case of renal cell carcinoma with lymph node metastasis keeping remission for five years by adjuvant immunotherapy with ubenimex]. Sugano O; Muto A; Kato M; Ono K Gan To Kagaku Ryoho; 2003 Oct; 30(10):1519-22. PubMed ID: 14584289 [TBL] [Abstract][Full Text] [Related]
9. [Metastatic renal tumor originating from lung cancer: a case report]. Maeda Y; Oyama H; Yoshimura K; Maeda H; Izutani T; Yamauchi T; Fukui I Hinyokika Kiyo; 1998 Jan; 44(1):33-5. PubMed ID: 9503206 [TBL] [Abstract][Full Text] [Related]
10. [Resection of solitary pulmonary cancer metastatic from renal cell carcinoma: a case report]. Okumura S; Kanamori S; Hasegawa J; Yoshida K; Nishimura T; Akimoto M Hinyokika Kiyo; 1984 Aug; 30(8):1063-7. PubMed ID: 6516997 [TBL] [Abstract][Full Text] [Related]
11. [Interferon and interleukin 2 in metastatic cancer of the kidney. Apropos of 18 cases]. Boaziz C; Breau JL; Morère JF; Raymond E; Moliard M; Israel L Ann Urol (Paris); 1991; 25(4):163-7. PubMed ID: 1746923 [TBL] [Abstract][Full Text] [Related]
12. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy. Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients. Figlin R; Gitlitz B; Franklin J; Dorey F; Moldawer N; Rausch J; deKernion J; Belldegrun A Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S92-7. PubMed ID: 9457402 [TBL] [Abstract][Full Text] [Related]
14. [Spontaneous regression of lung metastasis of renal cell carcinoma: a case report]. Yoshino S; Wakui M Hinyokika Kiyo; 1988 Dec; 34(12):2167-9. PubMed ID: 3239523 [TBL] [Abstract][Full Text] [Related]
15. [Spontaneous regression of pulmonary metastasis of cancer of the kidney. Apropos of a case occurring after the irradiation of a pelvic metastasis. Review of the literature]. Rodier JF; Rodier D; Janser JC; Navarrete E; Vergnes Y J Chir (Paris); 1988 May; 125(5):341-5. PubMed ID: 3290228 [TBL] [Abstract][Full Text] [Related]
16. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy. Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737 [TBL] [Abstract][Full Text] [Related]
17. [Gastric metastasis from renal cell carcinoma 20 months after radical nephrectomy: a case report]. Maeda T; Kozakai N; Nishiyama T; Ishii T; Sugiura H; Nakamura K Hinyokika Kiyo; 2009 Mar; 55(3):137-40. PubMed ID: 19378824 [TBL] [Abstract][Full Text] [Related]
18. [Pulmonary and lymph node metastases of renal cell carcinoma which completely responded to oral administration of UFT--a case report]. Hoshi K; Kanbara T; Kawasaki Y; Ikeda Y; Namima T; Ohnuma T Gan To Kagaku Ryoho; 2007 Aug; 34(8):1315-7. PubMed ID: 17687222 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma. Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106 [TBL] [Abstract][Full Text] [Related]
20. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials. Leibovich BC; Han KR; Bui MH; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun A Cancer; 2003 Dec; 98(12):2566-75. PubMed ID: 14669275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]